These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16822479)

  • 21. Down-regulation of estrogen receptor α (ERα) transcriptional activity by p27 is mediated by inhibition of ERα nuclear localization and modulation of the ERα transcriptional complex.
    Jeon MJ; Yang W; Seo HS; Wang ES; Shin I
    Cell Signal; 2012 Dec; 24(12):2249-58. PubMed ID: 22820506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.
    Kronblad A; Hedenfalk I; Nilsson E; Påhlman S; Landberg G
    Oncogene; 2005 Oct; 24(45):6835-41. PubMed ID: 16007158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.
    Kretzer NM; Cherian MT; Mao C; Aninye IO; Reynolds PD; Schiff R; Hergenrother PJ; Nordeen SK; Wilson EM; Shapiro DJ
    J Biol Chem; 2010 Dec; 285(53):41863-73. PubMed ID: 21041310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators.
    Wittmann BM; Sherk A; McDonnell DP
    Cancer Res; 2007 Oct; 67(19):9549-60. PubMed ID: 17909066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen and hypoxia regulate estrogen receptor alpha in a synergistic manner.
    Yi JM; Kwon HY; Cho JY; Lee YJ
    Biochem Biophys Res Commun; 2009 Jan; 378(4):842-6. PubMed ID: 19084502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the proteasome in the regulation of estrogen receptor alpha turnover and function in MCF-7 breast carcinoma cells.
    Laïos I; Journé F; Nonclercq D; Vidal DS; Toillon RA; Laurent G; Leclercq G
    J Steroid Biochem Mol Biol; 2005 Mar; 94(4):347-59. PubMed ID: 15857754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Aryl Hydrocarbon Receptor Ligand 6-Formylindolo(3,2-b)carbazole Promotes Estrogen Receptor Alpha and c-Fos Protein Degradation and Inhibits MCF-7 Cell Proliferation and Migration.
    Cano-Sánchez J; Murillo-González FE; de Jesús-Aguilar J; Cabañas-Cortés MA; Tirado-Garibay AC; Elizondo G
    Pharmacology; 2023; 108(2):157-165. PubMed ID: 36657432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.
    Powers GL; Ellison-Zelski SJ; Casa AJ; Lee AV; Alarid ET
    Oncogene; 2010 Mar; 29(10):1509-18. PubMed ID: 19946334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.
    Cooper C; Liu GY; Niu YL; Santos S; Murphy LC; Watson PH
    Clin Cancer Res; 2004 Dec; 10(24):8720-7. PubMed ID: 15623657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome.
    Calligé M; Kieffer I; Richard-Foy H
    Mol Cell Biol; 2005 Jun; 25(11):4349-58. PubMed ID: 15899841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clomiphene citrate down-regulates estrogen receptor-α through the ubiquitin-proteasome pathway in a human endometrial cancer cell line.
    Amita M; Takahashi T; Igarashi H; Nagase S
    Mol Cell Endocrinol; 2016 Jun; 428():142-7. PubMed ID: 27033325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis for an unexpected mode of SERM-mediated ER antagonism.
    Wu YL; Yang X; Ren Z; McDonnell DP; Norris JD; Willson TM; Greene GL
    Mol Cell; 2005 May; 18(4):413-24. PubMed ID: 15893725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trophic effect in MCF-7 cells of ERalpha17p, a peptide corresponding to a platform regulatory motif of the estrogen receptor alpha--underlying mechanisms.
    Gallo D; Haddad I; Duvillier H; Jacquemotte F; Laïos I; Laurent G; Jacquot Y; Vinh J; Leclercq G
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):138-49. PubMed ID: 18262408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination.
    Panno ML; Giordano F; Rizza P; Pellegrino M; Zito D; Giordano C; Mauro L; Catalano S; Aquila S; Sisci D; De Amicis F; Vivacqua A; Fuqua SW; Andò S
    Breast Cancer Res Treat; 2012 Nov; 136(2):443-55. PubMed ID: 23053665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines.
    Petrel TA; Brueggemeier RW
    J Cell Biochem; 2003 Jan; 88(1):181-90. PubMed ID: 12461787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term morphine treatment enhances proteasome-dependent degradation of G beta in human neuroblastoma SH-SY5Y cells: correlation with onset of adenylate cyclase sensitization.
    Moulédous L; Neasta J; Uttenweiler-Joseph S; Stella A; Matondo M; Corbani M; Monsarrat B; Meunier JC
    Mol Pharmacol; 2005 Aug; 68(2):467-76. PubMed ID: 15901846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Janus kinase 2--a novel negative regulator of estrogen receptor α function.
    Gupta N; Grebhardt S; Mayer D
    Cell Signal; 2012 Jan; 24(1):151-61. PubMed ID: 21907792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tamoxifen and Fulvestrant Hybrids Showed Potency as Selective Estrogen Receptor Down-Regulators.
    Shoda T; Kato M; Fujisato T; Demizu Y; Inoue H; Naito M; Kurihara M
    Med Chem; 2017; 13(3):206-213. PubMed ID: 27494098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells.
    Okuhira K; Demizu Y; Hattori T; Ohoka N; Shibata N; Nishimaki-Mogami T; Okuda H; Kurihara M; Naito M
    Cancer Sci; 2013 Nov; 104(11):1492-8. PubMed ID: 23992566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome.
    Berry NB; Fan M; Nephew KP
    Mol Endocrinol; 2008 Jul; 22(7):1535-51. PubMed ID: 18388150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.